<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">
hero-press-releases-1

Newsroom

Press Releases

Our latest announcements

Posts in: THE LANCET ONCOLOGY

Biodesix Announces Publication of Seminal PROSE Study in THE LANCET ONCOLOGY

May 14, 2014

Randomised Proteomic Stratified Phase III Study of Second Line Erlotinib Versus Chemotherapy in Patients with Inoperable Non-Small Cell Lung Cancer (PROSE)